Obstructive Sleep Apnea (OSA) is closely associated (comorbid) with a number of diseases, particularly obesity, diabetes, hypertension and cardiovascular disease.
Patients with these diseases are far more likely to have OSA. Treating it is proven to have a significant positive effect on primary diagnosis outcome; and treating OSA as the primary diagnosis can mitigate the likelihood of developing the comorbid diseases.
This document is intended to summarize just a few of the many clinical reports documenting the extent of the comorbidities and the impact of treatment.
The clinical study abstracts contained herein have been edited, replacing complex medical terminology with equally descriptive terms more likely to be understood by non-medical individuals.